Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer - New Molecular Aspects and their Potential as Targets

by Springer Netherland
State: New
$198.59
VAT included - FREE Shipping
Springer Netherland Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer - New Molecular Aspects and their Potential as Targets
Springer Netherland - Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer - New Molecular Aspects and their Potential as Targets

Do you like this product? Spread the word!

$198.59 incl. VAT
Only 1 items available Only 3 items available
Delivery: between Monday, September 27, 2021 and Wednesday, September 29, 2021
Sales & Shipping: Dodax EU

Check other buying options

1 Offer for $223.54

Sold by Dodax

$223.54 incl. VAT
State: New
Free Shipping
Delivery: between Monday, September 27, 2021 and Wednesday, September 29, 2021
View other buying options

Description

One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.


Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.

Further information

Editor:
Hiscox, Stephen;Hiscox
Gee, Julia;Gee
Nicholson, Robert I.;Nicholson
remarks:

Presents a clear and in-depth overview of both the clinical and scientific aspects of endocrine resistance in breast cancer


Includes emerging and novel themes in breast cancer resistance development


Reports up-to-date scientific and translational advances in this field

Media Type:
Hardcover
Publisher:
Springer Netherland
Language:
English
Number of Pages:
204
Summary:

Written by experts in the subject area, this timely book covers the molecular details and functional consequences of endocrine resistance in breast cancer. There is particular emphasis on the future applications of novel drug combinations.


Master Data

Product Type:
Hardback book
Package Dimensions:
0.236 x 0.155 x 0.015 m; 0.431 kg
GTIN:
09781402085253
DUIN:
IMT1639G2D1
Manufacturer Part Number:
25705330
$198.59
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.